Document:

-- Converted by SECPublisher 3.1.0.1, created by BCL Technologies Inc., for SEC Filing

EXHIBIT 4.4

WASHINGTON COMMERCIAL BANCORP DIRECTOR STOCK OPTION PLAN 

April 9, 2002 

	
1.      		
Purpose of the Plan. The purpose of this Director Stock Option Plan ("Plan") is to provide additional incentives to Directors of WASHINGTON COMMERCIAL
BANCORP, a Washington corporation ("Bancorp"), thereby helping to attract and retain the best available personnel for positions as directors of Bancorp and otherwise promoting the success of the business activities of
Bancorp. Bancorp intends that Options issued under this Plan will constitute nonqualified stock options.	
	 
	 
	
2.      		
Definitions. As used in this Plan, the following definitions apply:	
	 
	 	
a.      		
"Bancorp" has the meaning set forth in paragraph 1 of this Plan.	
	 
	 	
b.      		
"Board" means the Board of Directors of Bancorp.	
	 
	 	
c.      		
"Common Stock" means Bancorp's common stock, no par value.	
	 
	 	
d.      		
"Committee" has the meaning set forth in subparagraph 4(a) of this Plan.	
	 
	 	
e.      		
"Continuous Status as a Director" means the absence of any interruption or termination of service as a Director.	
	 
	 	
f.      		
"Date of Grant" of an Option means the date on which the Committee makes the determination granting such Option, or such later date as the Committee may designate. The Date of Grant shall be specified in the Option
agreement.	
	 
	 	
g.      		
"Director" means any person serving as a member of the Board of Bancorp or a Subsidiary of Bancorp which is currently in existence or is hereafter organized or is acquired by Bancorp.	
	 
	 	
h.      		
"Exercise Price" has the meaning set forth in subparagraph 4(b)(2) of this Plan.	
	 
	 	
i.      		
"Option" means a stock option granted under this Plan, which constitutes a Nonqualified Stock Option.	
	 
	 	
j.      		
"Optionee" means a Director who receives an Option.	
	 
	 	
k.      		
"Plan" has the meaning set forth in paragraph 1 of this Plan.	
	 

 "Parent" means any corporation owning at least eighty percent (80%) of the total voting power of the issued and outstanding stock of Bancorp, and eighty percent (80%) of the total value of the issued and outstanding stock of
Bancorp. 

	
l.      		
"Subsidiary" means any bank or other corporation of which not less than fifty percent (50%) of the voting shares are held by Bancorp or a
Subsidiary, whether or not such corporation now exists or is hereafter organized or acquired by Bancorp or a Subsidiary.	
	 

	
3.      		
Stock Subject to Options.	
	 
	 	
a.      		
Number of Shares Reserved. The maximum number of shares which may
be optioned and sold under this Plan is 24,129 shares of the Common Stock of Bancorp (subject to adjustment as provided in subparagraph 6(j) of this Plan). During the term of this Plan, Bancorp will at all times reserve and
keep available a sufficient number of shares of its Common Stock to satisfy the requirements of this Plan. 	
	 	
 	
 
	 	
b.	
Expired Options.
If any outstanding Option expires or becomes unexercisable for any reason
without having been exercised in full, the shares of Common Stock allocable to
the unexercised portion of such Option will again become available for other
Options.	

	 

	
4.      		
Administration of the Plan.	
	 
	 	
a.      		
The Committee. The Board will administer this Plan directly, acting as a Committee of the whole, or if the Board elects, by a separate Committee appointed by the Board for that purpose
and consisting of at least three Board members. All references in the Plan to the "Committee" refers to this separate Committee, if any is established, or if none is then in existence, refers to the Board as a whole. Once appointed, any Committee
will continue to serve until otherwise directed by the Board.
From time to time, the Board may increase the size of the Committee and appoint additional members, remove members (with or without cause), appoint new members in substitution, and fill vacancies however caused. The Committee
will select one of its members as chairman, and will hold meetings at such times and places as the chairman or a majority of the Committee may determine. At all times, the Board will have the power to remove all members of the Committee and
thereafter to directly administer this Plan as a Committee of the whole.	
	 
	 	 	
(1)      		
Members of the Committee who are eligible for Options or who have been granted Options will be counted for all purposes in determining the existence of a quorum at any meeting of the Committee and will be eligible to vote on
all matters before the Committee respecting the granting of Options or administration of this Plan.	
	 

	 	 	
(2)      		
At least annually, the Committee must present a written report to the Board indicating the Directors to whom Options have been granted since the date of the last such report, and in each case the Date of Grant, the number of
shares optioned, and the per-share Exercise Price.	
	 
	
 	
b.      		
Powers of the Committee. All actions of the Committee must be either (i) by a majority vote of the members of the full Committee at a meeting of the Committee, or (ii) by unanimous
written consent of all members of the full Committee without a meeting. All decisions, determinations and interpretations of the Committee will be final and binding on all persons, including all Optionees and any other holders or persons interested
in any Options, unless otherwise expressly determined by a vote of the majority of the entire Board. No member of the Committee or of the Board will be liable for any action or determination made in good faith with respect to the Plan or any Option.
Subject to all provisions and limitations of the Plan, the Committee will have the authority and discretion:	
	 
	 	 	
(1)      		
to determine the Directors to whom Options are to be granted, the Dates of Grant, and the number of shares to be represented by each Option;	
	 
	 	 	
(2)      		
to determine the price at which shares of Common Stock are to be issued under an Option, subject to subparagraph 6(b) of this Plan ("Exercise Price");	
	 
	 	 	
(3)      		
to determine all other terms and conditions of each Option granted under this Plan (including specification of the dates upon which Options become exercisable, and whether conditioned on performance standards, periods of
service or otherwise), which terms and conditions can vary between Options;	
	 
	 	 	
(4)      		
to modify or amend the terms of any Option previously granted, or to grant substitute Options, subject to subparagraphs 6(l) and 6(m) of this Plan;	
	 
	 	 	
(5)      		
to authorize any person or persons to execute and deliver Option agreements or to take any other actions deemed by the Committee to be necessary or appropriate to effect the grant of Options by the Committee;	
	 

	 	 	
 (6)

 	
to interpret this Plan and to make all other determinations and take
 all other actions which the Committee deems necessary or appropriate to administer this Plan in accordance with its terms and conditions.	
	 
	
 	
5.      		
Eligibility. Options may be granted only to Directors. Granting of Options under this Plan will be entirely discretionary with the Committee. Adoption of this Plan will not confer on any
Director any right to receive any Option or Options under this Plan unless and until said Options are granted by the Committee, in its sole discretion. Neither the adoption of this Plan nor the granting of any Options under this Plan will confer
upon any Director or Optionee any right with respect to continuation of status as a Director, nor will the same interfere in any way with his or her right or with the right of the shareholders of Bancorp or any Subsidiary to terminate his or her
status as a Director at any time.	
	 
	
 	
6.      		
Terms and Conditions of Options. All Options granted under this Plan must be authorized by the Committee, and must be documented in written Option agreements in such form as the Committee
will approve from time to time, which agreements must comply with and be subject to all of the following terms and conditions:	
	 
	 	
a.

 	
      		
Number of Shares. Each Option agreement must state the number of shares subject to Option. Any number of Options may be granted to a single eligible Director at any time and from time to
time.	
	 
	 	
b.

 	
      		
Exercise Price and Consideration. Each option agreement must state the Exercise Price for the shares of Common Stock to be issued under the Option, which price must be not less than the
greater of (1) the fair market value of the Common Stock or (2) the net book value of the Common Stock at the time of grant, as is determined by the Committee. The Exercise Price is payable either (i) in United States dollars upon exercise of the
Options, or (ii) if approved by the Board or Committee, other consideration including without limitation Common Stock of Bancorp, services, or other property.	
	 
	 	
c.

 	
      		
Term of Option. Subject to other applicable provisions of this Plan including but not limited to subparagraphs 6(g), 6(h) and 6(i), the term of each Option will be determined by the
Committee in its discretion.	
	 
	 	
d.

 	
      		
Non-transferability of Options. No Option may be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will
or by the laws of descent or distribution and may be exercised, during the lifetime of the Optionee, only by the Optionee.	
	 

	
 	
e.	
      		
Manner of Exercise. An Option will be deemed to be exercised when written notice of exercise has been given to Bancorp in accordance with the terms of the Option by the person entitled to
exercise the Option, together with full payment for the shares of Common Stock subject to said notice.	
	 
	
 	
f. 		
     		
Rights as Shareholder. An Optionee shall have none of the rights of a shareholder with respect to any shares covered by his or her Option unless and until the Optionee has exercised such
Option and submitted full payment for the shares.	
	 
	
 	
g. 		
     		
Death of Optionee. In the event of the death of an Optionee who at the time of his or her death was a Director and who had been in Continuous Status as a Director since the Date of Grant
of the Option, the Option will terminate on the earlier of (i) one year after the date of death of the Optionee, or (ii) the expiration date otherwise provided in the Option agreement, except that if the expiration date should occur during the 180-
day period immediately following the Optionee's death, such Option will terminate at the end of such 180-day period. The Option will be exercisable at any time prior to such termination by the Optionee's estate, or by such person or persons who have
acquired the right to exercise the Option by bequest or by inheritance or by reason of the death of the Optionee.	
	 
	
 	
h.	
      		
Disability of Optionee. If an Optionee's status as a Director is terminated at any time during the Option period by reason of a disability (within the meaning of Section 22(e)(3) of the
Internal Revenue Code) and if said Optionee had been in Continuous Status as a Director at all times between the Date of Grant of the Option and the termination of his or her status as a Director, his or her Option will terminate on the earlier of
(i) one year after the date of termination of his or her status as a Director, or (ii) the expiration date otherwise provided in his or her Option agreement.	
	 
	
 	
 	
i.      		
Termination of Status as a Director.	
	
 	
 	
 	
 
	
 	
 	
(1)    		
if an Optionee's status as a Director is terminated at any time after the grant of an Option to such Director for any reason other than death or disability, as provided in subparagraphs 6(g) and 6(h) of this Plan, and
excepting if the Director is removed for cause, as
provided in subparagraph (2) below, such Option will terminate on the earlier of (i) the same day of the sixth month after the date of termination of his or her status as a Director, or (ii) the expiration date otherwise
provided in his or her Option agreement.	
	 

	 	 	
 
	 
	 	 	
(2)      		
If an Optionee is removed as a Director for cause at any time after the grant of an Option to such Director, then such Option will terminate on the date of termination of his or her status as a Director. For this purpose,
cause will be deemed to exist only if the Board has reasonable grounds to believe that Bancorp has suffered or will suffer substantial injury as a result of the gross negligence or dishonesty of the Director who is removed.	
	 
	
 	
j.      		
Adjustments Upon Changes in Capitalization. Subject to any required action by the shareholders of Bancorp, the number of shares of Common Stock covered by each outstanding Option, the
number of shares of Common Stock available for grant of additional Options, and the per-share Exercise Price in each outstanding Option, will be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock
resulting from any stock split or other subdivision or consolidation of shares, the payment of any stock dividend (but only on the Common Stock) or any other increase or decrease in the number of such shares of Common Stock effected without receipt
of consideration by Bancorp; provided, however, that conversion of any convertible securities of Bancorp will not be deemed to have been "effected without receipt of
consideration." Such adjustment will be made by the Committee, whose determination in that respect will be final, binding and conclusive.	
	 
	 	 	
(1)      		
Except as otherwise expressly provided in this subparagraph 6(j), no Optionee will have any rights by reason of any stock split or the payment of any stock dividend or any other increase or decrease in the number of shares of
Common Stock, and no issuance by Bancorp of shares of stock of any class, or securities convertible into shares of stock of any class, will affect the number of shares or Exercise Price subject to any Options, and no adjustments in Options will be
made by reason thereof. The grant of an Option under this Plan will not affect in any way the right or power of Bancorp to make adjustments, reclassifications, reorganizations or changes of its capital or business structure.	
	 
	
 	
k.      		
Conditions Upon Issuance of Shares. Shares of Common Stock will not be issued with respect to an Option granted under this Plan unless the exercise of such Option and the issuance and
delivery of such shares pursuant thereto will comply with all applicable provisions of law, including
applicable federal and state securities laws. As a condition to the exercise of an Option, Bancorp may require the person exercising such Option to represent and warrant at the time of exercise that the shares of Common Stock
are being purchased only for investment and without any present intention to sell or distribute such Common Stock if, in the opinion of counsel for Bancorp, such a representation is required by any of the aforementioned relevant provisions of
law.	
	 

	
 	
l.      		
Corporate Sale Transactions. In the event of the merger or reorganization of Bancorp with or into any other corporation, the sale of substantially all of the assets of Bancorp, or a
dissolution or liquidation of Bancorp (collectively, "Sale Transaction"), (1) all outstanding Options that are not then fully exercisable will become exercisable upon the date of closing of any sale transaction or such earlier date as the Committee
may fix; and (2) the Committee may, in the exercise of its sole discretion, terminate all outstanding Options as of a date fixed by the Committee. In such event, however, the Committee must notify each Optionee of such action in writing not less
than sixty (60) days prior to the termination date fixed by the Committee, and each Optionee must have the right to exercise his or her Option prior to said termination date.	
	 
	
 	
m.      		
Substitute Stock Options. In connection with an internal reorganization of Bancorp (e.g., formation of a holding company), the Committee is authorized, in its discretion, to substitute
for any unexercised Option, a new option for shares of the resulting entity's stock.	
	 
	
 	
n.      		
Tax Compliance. Bancorp, in its sole discretion, may take actions reasonably believed by it to be required to comply with any local, state, or federal tax laws relating to the reporting
or withholding of taxes attributable to the grant or exercise of any Option or the disposition of any shares of Common Stock issued upon exercise of an Option, including, but not limited to (i) withholding from any Optionee exercising an Option a
number of shares of Common Stock having a fair market value equal to the amount required to be withheld by Bancorp under applicable tax laws, and (ii) withholding from any form of compensation or other amount due an Optionee, or holder, of shares of
Common Stock issued upon exercise of an Option any amount required to be withheld by Bancorp under applicable tax laws. Withholding or reporting will be considered required for purposes of this subparagraph if the Committee, in its sole discretion,
so determines.	
	 
	
 	
o.      		
Other Provisions. Option agreements executed under this Plan may contain such other provisions as the Committee will deem advisable.	
	 

	
7.      		
Term of the Plan. This Plan will become effective and Options may be granted upon the Plan's approval by the Board, subject to shareholder approval. Unless sooner terminated as provided
in subparagraph 7(a) of this Plan, this Plan will terminate on the tenth (10th) anniversary of its effective date. Options may be granted at any time after the effective date and prior to the date of termination of this Plan.	
	 
	 	
a.      		
Amendment or Early Termination of the Plan. The Board may terminate this Plan at any time. The Board may amend this Plan at any time and from time to time in such respects as the Board
may deem advisable, except that, without approval of the shareholders, no revision or amendment will increase the number of shares of Common Stock subject to this Plan other than in connection with an adjustment under subparagraph 6(j) of this
Plan.	
	 
	 	
b.      		
Effect of Amendment or Termination. No amendment or termination of this Plan will affect Options granted prior to such amendment or termination, and all such Options will remain in full
force and effect notwithstanding such amendment or termination.	
	 
	
8.      		
Shareholder Approval. Adoption of this Plan will be subject to ratification by affirmative vote of shareholders owning at least a majority of the outstanding Common Stock of Bancorp at a
duly convened meeting.	
	 

* * * * *

CERTIFICATE OF ADOPTION

 I certify that the foregoing Director Stock Option Plan was approved by the Board of Directors of Washington Commercial Bancorp on February 13, 2002. 

     I further certify that the foregoing Director Stock Option Plan was approved by the shareholders of Washington Commercial Bancorp on April 9, 2002. 

                                        Jeffrey R. Hill, SecretaryEXHIBIT 4.1

NEITHER THESE WARRANTS NOR THE COMMON STOCK ISSUABLE UPON EXERCISE OF THESE
WARRANTS HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, PLEDGED OR
TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH
SECURITIES UNDER THE ACT OR UNLESS AN EXEMPTION FROM SUCH REGISTRATION IS
AVAILABLE.

2,400,000 WARRANTS                                            SEPTEMBER 14, 2005

                           ADVANCED BIOPHOTONICS, INC.

                                    WARRANTS

         Advanced BioPhotonics, Inc., a Delaware corporation ("ABPH"), certifies
that, for value received, Trilogy Capital Partners, Inc. ("TRILOGY"), or
registered assigns (the "HOLDER"), is the owner of Two Million Four Hundred
Thousand (2,400,000) Warrants of ABPH (the "WARRANTS"). Each Warrant entitles
the Holder to purchase from ABPH at any time prior to the Expiration Date (as
defined below) one share of the common stock of ABPH (the "COMMON STOCK") for
$0.50 per share (the "EXERCISE PRICE"), on the terms and conditions hereinafter
provided. The Exercise Price and the number of shares of Common Stock
purchasable upon exercise of each Warrant are subject to adjustment as provided
in this Certificate.

1. VESTING; EXPIRATION DATE; EXERCISE

     1.1 Vesting. The Warrants shall vest and become exercisable as of the date
of this Certificate.

     1.2 Expiration Date. The Warrants shall expire on September 14, 2008 (the
"EXPIRATION DATE").

     1.3 Manner of Exercise. The Warrants are exercisable by delivery to ABPH of
the following (the "EXERCISE DOCUMENTS"): (a) this Certificate (b) a written
notice of election to exercise the Warrants; and (c) payment of the Exercise
Price in cash, by check or by "net" exercise as contemplated by Section 1.4 of
this Certificate. Within three business days following receipt of the foregoing,
ABPH shall execute and deliver to the Holder: (a) a certificate or certificates
representing the aggregate number of shares of Common Stock purchased by the
Holder, and (b) if less than all of the Warrants evidenced by this Certificate
are exercised, a new certificate evidencing the Warrants not so exercised.

<PAGE>

     1.4 Net Exercise. In lieu of the payment methods set forth in Section 1.3
above, the Holder may elect to exchange all or some of the Warrant for the
number of shares of Common Stock computed using the following formula:

                  X = Y (A-B)
                  -----------
                       A

                  Where X = the number of shares of Common Stock to be issued to
                  Holder.

                  Y = the number of shares of Common Stock purchasable under the
                  Warrants being exchanged (as adjusted to the date of such
                  calculation).

                  A = the Market Price on the date of receipt by ABPH of the
                  exercise documents.

                  B = the Exercise Price of the Warrants being exchanged (as
                  adjusted in accordance with the terms of Section 2 hereof).

                  The "MARKET PRICE" on any trading day shall be deemed to be
         the last reported sale price of the Common Stock on such day, or, in
         the case no such reported sales take place on such day, the last
         reported sale price on the preceding trading day on which there was a
         last reported sales price, as officially reported by the principal
         securities exchange in which the shares of Common Stock are listed or
         admitted to trading or by the Nasdaq Stock Market, or if the Common
         Stock is not listed or admitted to trading on any national securities
         exchange or the Nasdaq Stock Market, the last sale price, or if there
         is no last sale price, the closing bid price, as furnished by the
         National Association of Securities Dealers, Inc. (such as through the
         OTC Bulletin Board) or a similar organization or if Nasdaq is no longer
         reporting such information. If the Market Price cannot be determined
         pursuant to the sentence above, the Market Price shall be determined in
         good faith (using customary valuation methods) by the Board of
         Directors of ABPH based on the information best available to it,
         including recent arms-length sales of Common Stock to unaffiliated
         persons.

     1.5 Warrant Exercise Limitation. Notwithstanding any other provision of
this Agreement, if as of the date of exercise ABPH has a class of securities
registered under Section 12 of the Securities Exchange Act of 1934, as amended,
Holder may not exercise Warrants under this Section 1 to the extent that
immediately following such exercise Holder would beneficially own 5% or more of
the outstanding Common Stock of ABPH. For this purpose, a representation of the
Holder that following such exercise it would not beneficially own 5% or more of
the outstanding Common Stock of ABPH shall be conclusive and binding upon ABPH.

2. ADJUSTMENTS OF EXERCISE PRICE AND NUMBER AND KIND OF CONVERSION SHARES

     2.1 In the event that ABPH shall at any time hereafter (a) pay a dividend
in Common Stock or securities convertible into Common Stock; (b) subdivide or
split its outstanding Common Stock; (c) combine its outstanding Common Stock
into a smaller number of shares; then the number of shares to be issued
immediately after the occurrence of any such event shall be adjusted so that the
Holder thereafter may receive the number of shares of Common Stock it would have
owned immediately

                                     - 2 -
<PAGE>

following such action if it had exercised the Warrants immediately prior to such
action and the Exercise Price shall be adjusted to reflect such proportionate
increases or decreases in the number of shares.

     2.2 In case of any reclassification of the outstanding shares of Common
Stock (other than a change covered by Section 2.1 hereof or a change which
solely affects the par value of such shares) or in the case of any merger or
consolidation or merger in which ABPH is not the continuing corporation and
which results in any reclassification or capital reorganization of the
outstanding shares), the Holder shall have the right thereafter (until the
Expiration Date) to receive upon the exercise hereof, for the same aggregate
Exercise Price payable hereunder immediately prior to such event, the kind and
amount of shares of stock or other securities or property receivable upon such
reclassification, capital reorganization, merger or consolidation, by a Holder
of the number of shares of Common Stock obtainable upon the exercise of the
Warrants immediately prior to such event; and if any reclassification also
results in a change in shares covered by Section 2.1, then such adjustment shall
be made pursuant to both this Section 2.2 and Section 2.1 (without duplication).
The provisions of this Section 2.2 shall similarly apply to successive
reclassifications, capital reorganizations and mergers or consolidations, sales
or other transfers.

3. RESERVATION OF SHARES. ABPH shall at all times reserve and keep available out
of its authorized but unissued shares of Common Stock, such number of shares of
Common Stock as shall from time to time be issuable upon exercise of the
Warrants. If at any time the number of authorized but unissued shares of Common
Stock shall not be sufficient to permit the exercise of the Warrants, ABPH shall
promptly seek such corporate action as may necessary to increase its authorized
but unissued shares of Common Stock to such number of shares as shall be
sufficient for such purpose.

4. CERTIFICATE AS TO ADJUSTMENTS. In each case of any adjustment in the Exercise
Price, or number or type of shares issuable upon exercise of these Warrants, the
Chief Financial Officer of ABPH shall compute such adjustment in accordance with
the terms of these Warrants and prepare a certificate setting forth such
adjustment and showing in detail the facts upon which such adjustment is based,
including a statement of the adjusted Exercise Price. ABPH shall promptly send
(by facsimile and by either first class mail, postage prepaid or overnight
delivery) a copy of each such certificate to the Holder.

5. LOSS OR MUTILATION. Upon receipt of evidence reasonably satisfactory to ABPH
of the ownership of and the loss, theft, destruction or mutilation of this
Certificate, and of indemnity reasonably satisfactory to it, and (in the case of
mutilation) upon surrender and cancellation of these Warrants, ABPH will execute
and deliver in lieu thereof a new Certificate of like tenor as the lost, stolen,
destroyed or mutilated Certificate.

6. REPRESENTATIONS AND WARRANTIES OF ABPH. ABPH hereby represents and warrants
to Holder that:

     6.1 Due Authorization. All corporate action on the part of ABPH, its
officers, directors and shareholders necessary for (a) the authorization,
execution and delivery of, and the performance of all obligations of ABPH under,
these Warrants, and (b) the authorization, issuance, reservation for issuance
and delivery of all of the Common Stock issuable upon exercise of these
Warrants, has been duly taken. These Warrants constitute a valid and binding
obligation of ABPH enforceable in accordance with their

                                     - 3 -
<PAGE>

terms, subject, as to enforcement of remedies, to applicable bankruptcy,
insolvency, moratorium, reorganization and similar laws affecting creditors'
rights generally and to general equitable principles.

     6.2 Organization. ABPH is a corporation duly organized, validly existing
and in good standing under the laws of the State referenced in the first
paragraph of this Certificate and has all requisite corporate power to own,
lease and operate its property and to carry on its business as now being
conducted and as currently proposed to be conducted.

     6.3 Valid Issuance of Stock. Any shares of Common Stock issued upon
exercise of these Warrants will be duly and validly issued, fully paid and
non-assessable.

     6.4 Governmental Consents. All consents, approvals, orders, authorizations
or registrations, qualifications, declarations or filings with any federal or
state governmental authority on the part of ABPH required in connection with the
consummation of the transactions contemplated herein have been obtained.

7. REPRESENTATIONS AND WARRANTIES OF TRILOGY. Trilogy hereby represents and
warrants to ABPH that:

     7.1 Trilogy is acquiring the Warrants for its own account, for investment
purposes only.

     7.2 Trilogy understands that an investment in the Warrants involves a high
degree of risk, and Trilogy has the financial ability to bear the economic risk
of this investment in the Warrants, including a complete loss of such
investment. Trilogy has adequate means for providing for its current financial
needs and has no need for liquidity with respect to this investment.

     7.3 Trilogy has such knowledge and experience in financial and business
matters that it is capable of evaluating the merits and risks of an investment
in the Warrants and in protecting its own interest in connection with this
transaction.

     7.4 Trilogy understands that the Warrants have not been registered under
the Securities Act of 1933, as amended (the "SECURITIES ACT") or under any state
securities laws. Trilogy is familiar with the provisions of the Securities Act
and Rule 144 thereunder and understands that the restrictions on transfer on the
Warrants may result in Trilogy being required to hold the Warrants for an
indefinite period of time.

     7.5 Trilogy agrees not to sell, transfer, assign, gift, create a security
interest in, or otherwise dispose of, with or without consideration
(collectively, "TRANSFER") any of the Warrants except pursuant to an effective
registration statement under the Securities Act or an exemption from
registration. As a further condition to any such Transfer, except in the event
that such Transfer is made pursuant to an effective registration statement under
the Securities Act, if in the reasonable opinion of counsel to ABPH any Transfer
of the Warrants by the contemplated transferee thereof would not be exempt from
the registration and prospectus delivery requirements of the Securities Act,
ABPH may require the contemplated transferee to furnish ABPH with an investment
letter setting forth such information and agreements as may be reasonably
requested by ABPH to ensure compliance by such transferee with the Securities
Act.

                                     - 4 -
<PAGE>

8. NOTICES OF RECORD DATE

     In the event:

     8.1 ABPH shall take a record of the holders of its Common Stock (or other
stock or securities at the time receivable upon the exercise of these Warrants),
for the purpose of entitling them to receive any dividend or other distribution,
or any right to subscribe for or purchase any shares of stock of any class or
any other securities or to receive any other right; or

     8.2 of any consolidation or merger of ABPH with or into another
corporation, any capital reorganization of ABPH, any reclassification of the
capital stock of ABPH, or any conveyance of all or substantially all of the
assets of ABPH to another corporation in which holders of ABPH's stock are to
receive stock, securities or property of another corporation; or

     8.3 of any voluntary dissolution, liquidation or winding-up of ABPH; or

     8.4 of any redemption or conversion of all outstanding Common Stock;

then, and in each such case, ABPH will mail or cause to be mailed to the Holder
a notice specifying, as the case may be, (a) the date on which a record is to be
taken for the purpose of such dividend, distribution or right, or (b) the date
on which such reorganization, reclassification, consolidation, merger,
conveyance, dissolution, liquidation, winding-up, redemption or conversion is to
take place, and the time, if any is to be fixed, as of which the holders of
record of Common Stock (or such stock or securities as at the time are
receivable upon the exercise of these Warrants), shall be entitled to exchange
their shares of Common Stock (or such other stock or securities), for securities
or other property deliverable upon such reorganization, reclassification,
consolidation, merger, conveyance, dissolution, liquidation or winding-up. ABPH
shall use all reasonable efforts to ensure such notice shall be delivered at
least 15 days prior to the date therein specified.

9. REGISTRATION RIGHTS.

     9.1 Definitions. For purposes of this Section 9, the following terms shall
have the meanings set forth below:

         9.1.1 A "BLACKOUT EVENT" means any of the following: (a) the possession
by ABPH of material information that is not ripe for disclosure in a
registration statement or prospectus, as determined reasonably and in good faith
by the Chief Executive Officer or the Board of Directors of ABPH or that
disclosure of such information in the Registration Statement or the prospectus
constituting a part thereof would be materially detrimental to the business and
affairs of ABPH; or (b) any material engagement or activity by ABPH which would,
in the reasonable and good faith determination of the Chief Executive Officer or
the Board of Directors of ABPH, be materially adversely affected by disclosure
in a registration statement or prospectus at such time.

         9.1.2 "EXCHANGE ACT" shall mean the Securities Exchange Act of 1934, as
amended.

                                     - 5 -
<PAGE>

         9.1.3 "INCLUDED SHARES" shall mean any Registrable Shares included in a
Registration.

         9.1.4 "REGISTRABLE SHARES" shall mean the shares of Common Stock (or
such stock or securities as at the time are receivable upon the exercise of
these Warrants) issuable upon exercise of the Warrants and any other warrants
and or other securities issued to Trilogy in connection with performing investor
relations services for ABPH, and shares or securities issued as a result of
stock split, stock dividend or reclassification of such shares.

         9.1.5 "REGISTRATION" shall mean a registration of securities under the
Securities Act pursuant to Section 9.2 or 9.3 of this Agreement.

         9.1.6 "REGISTRATION PERIOD" with respect to any Registration Statement
the period commencing the effective date of the Registration Statement and
ending upon withdrawal or termination of the Registration Statement.

         9.1.7 "REGISTRATION STATEMENT" shall mean the registration statement,
as amended from time to time, filed with the SEC in connection with a
Registration.

         9.1.8 "SEC" shall mean the Securities and Exchange Commission.

     9.2 Demand Registration. No later than October 29, 2005, ABPH shall prepare
and file with the SEC a Registration Statement for the purpose of registering
the sale of the Registrable Shares under the Securities Act, and shall use its
commercially reasonable efforts to cause the Registration Statement to become
effective within 60 days of the date of filing. Once effective, ABPH shall
prepare and file with the SEC such amendments and supplements to the
Registration Statement and the prospectus forming a part thereof as may be
necessary to keep the Registration Statement effective until the earliest date
on which (a) all the Included Shares have been disposed of pursuant to the
Registration Statement, or (b) all of the Included Shares then held by Holder
may be sold under the provisions of Rule 144 without limitation as to volume,
whether pursuant to Rule 144(k) or otherwise.

     9.3 Piggyback Registration. Unless the Registrable Shares are then included
in a Registration Statement or can be sold under the provisions of Rule 144
without limitation as to volume, whether pursuant to Rule 144(k) or otherwise,
if ABPH shall determine to register any Common Stock under the Securities Act
for sale in connection with a public offering of Common Stock (other than
pursuant to an employee benefit plan or a merger, acquisition or similar
transaction), ABPH will give written notice thereof to Holder and will include
in such Registration Statement any of the Registrable Shares which Holder may
request be included ("INCLUDED SHARES") by a writing delivered to ABPH within 15
days after the notice given by ABPH to Holder; provided, however, that if the
offering is to be firmly underwritten, and the representative of the
underwriters of the offering refuse in writing to include in the offering all of
the shares of Common Stock requested by ABPH and others, the shares to be
included shall be allocated first to ABPH and any shareholder who initiated such
Registration and then among the others based on the respective number of shares
of Common Stock held by such persons. If ABPH decides not to, and does not, file
a Registration Statement with respect to such Registration, or after filing
determines to withdraw the same before the effective date thereof, ABPH will
promptly so inform Holder, and ABPH will not be obligated to complete the
registration of the Included Shares included therein.

                                     - 6 -
<PAGE>

     9.4 Certain Covenants. In connection with any Registration:

         9.4.1 ABPH shall take all lawful action such that the Registration
Statement, any amendment thereto and the prospectus forming a part thereof does
not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they are made, not misleading. Upon
becoming aware of the occurrence of any event or the discovery of any facts
during the Registration Period that make any statement of a material fact made
in the Registration Statement or the related prospectus untrue in any material
respect or which material fact is omitted from the Registration Statement or
related prospectus that requires the making of any changes in the Registration
Statement or related prospectus so that it will not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements therein, in light of the circumstances under which they are made, not
misleading (taking into account any prior amendments or supplements), ABPH shall
promptly notify Holder, and, subject to the provisions of Section 9.5, as soon
as reasonably practicable prepare (but, subject to Section 9.5, in no event more
than five business days in the case of a supplement or seven business days in
the case of a post-effective amendment) and file with the SEC a supplement or
post-effective amendment to the Registration Statement or the related prospectus
or file any other required document so that, as thereafter delivered to a
purchaser of Shares from Holder, such prospectus will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements therein, in light of the circumstances under which they were
made, not misleading.

         9.4.2 At least three business days prior to the filing with the SEC of
the Registration Statement (or any amendment thereto) or the prospectus forming
a part thereof (or any supplement thereto), ABPH shall provide draft copies
thereof to Holder and shall consider incorporating into such documents such
comments as Holder (and its counsel) may propose to be incorporated therein.
Notwithstanding the foregoing, no prospectus supplement, the form of which has
previously been provided to Holder, need be delivered in draft form to Holder.

         9.4.3 ABPH shall promptly notify Holder upon the occurrence of any of
the following events in respect of the Registration Statement or the prospectus
forming a part thereof: (a) the receipt of any request for additional
information from the SEC or any other federal or state governmental authority,
the response to which would require any amendments or supplements to the
Registration Statement or related prospectus; (b) the issuance by the SEC or any
other federal or state governmental authority of any stop order suspending the
effectiveness of the Registration Statement or the initiation of any proceedings
for that purpose; or (c) the receipt of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the
Shares for sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose.

         9.4.4 ABPH shall furnish to Holder with respect to the Included Shares
registered under the Registration Statement (and to each underwriter, if any, of
such Shares) such number of copies of prospectuses and such other documents as
Holder may reasonably request, in order to facilitate the public sale or other
disposition of all or any of the Included Shares by Holder pursuant to the
Registration Statement.

         9.4.5 In connection with any registration pursuant to Section 9.2, ABPH
shall file or cause to be filed such documents as are required to be filed by
ABPH for normal Blue Sky clearance in

                                     - 7 -
<PAGE>

states specified in writing by Holder; provided, however, that ABPH shall not be
required to qualify to do business or consent to service of process in any
jurisdiction in which it is not now so qualified or has not so consented.

         9.4.6 ABPH shall bear and pay all expenses incurred by it and Holder
(other than underwriting discounts, brokerage fees and commissions and fees and
expenses of more than one law firm) in connection with the registration of the
Shares pursuant to the Registration Statement.

         9.4.7 ABPH shall require each legal opinion and accountant's "cold
comfort" letter in connection with the Registration, if any, to be rendered to
Holder as well as ABPH and/or its Board of Directors.

         9.4.8 As a condition to including Registrable Shares in a Registration
Statement, Holder must provide to ABPH such information regarding itself, the
Registrable Shares held by it and the intended method of distribution of such
Shares as shall be required to effect the registration of the Registrable Shares
and, if the offering is being underwritten, Holder must provide such powers of
attorney, indemnities and other documents as may be reasonably requested by the
managing underwriter.

         9.4.9 Following the effectiveness of the Registration Statement, upon
receipt from ABPH of a notice that the Registration Statement contains an untrue
statement of material fact or omits to state any material fact required to be
stated therein or necessary to make the statements therein not misleading in
light of the circumstances under which they were made, Holder will immediately
discontinue disposition of Included Shares pursuant to the Registration
Statement until ABPH notifies Holder that it may resume sales of Included Shares
and, if necessary, provides to Holder copies of the supplemental or amended
prospectus.

     9.5 Blackout Event. ABPH shall not be obligated to file a post-effective
amendment or supplement to the Registration Statement or the prospectus
constituting a part thereof during the continuance of a Blackout Event;
provided, however, that no Blackout Event may be deemed to exist for more than
60 days. Without the express written consent of Holder, if required to permit
the continued sale of Shares by Holder, a post-effective amendment or supplement
to Registration Statement or the prospectus constituting a part thereof must be
filed no later than the 61st day following commencement of a Blackout Event.

     9.6 Rule 144. With a view to making available to Holder the benefits of
Rule 144, ABPH agrees, until such time as Holder can sell all remaining
Registrable Shares under the provisions Rule 144(k), to:

         9.6.1 comply with the provisions of paragraph (c)(1) of Rule 144; and

         9.6.2 file with the SEC in a timely manner all reports and other
documents required to be filed by ABPH pursuant to Section 13 or 15(d) under the
Exchange Act; and, if at any time it is not required to file such reports but in
the past had been required to or did file such reports, it will, upon the
request of a Purchaser, make available other information as required by, and so
long as necessary to permit sales of its Shares pursuant to, Rule 144.

                                     - 8 -
<PAGE>

     9.7 ABPH Indemnification. ABPH agrees to indemnify and hold harmless
Holder, and its officers, directors and agents (including broker or underwriter
selling Included Shares for Holder), and each person, if any, who controls
Holder within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act from and against any and all losses, claims, damages and
liabilities caused by (a) any violation or alleged violation by ABPH of the
Securities Act, Exchange Act, any state securities laws or any rule or
regulation promulgated under the Securities Act, Exchange Act or any state
securities laws, (b) any untrue statement or alleged untrue statement of a
material fact contained in any registration statement or prospectus relating to
the Included Shares (as amended or supplemented if ABPH shall have furnished any
amendments or supplements thereto) or any preliminary prospectus, or (c) caused
by any omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading in
light of the circumstances under which they were made, except insofar as such
losses, claims, damages or liabilities are caused by any such untrue statement
or omission or alleged untrue statement or omission based upon information
furnished in writing to ABPH by Holder or on Holder's behalf expressly for use
therein.

     9.8 Holder Indemnification. Holder agrees to indemnify and hold harmless
ABPH, its officers, directors and agents and each person, if any, who controls
ABPH within the meaning of either Section 15 of the Securities Act or Section 20
of the Exchange Act to the same extent as the foregoing indemnity from ABPH to
Holder, but only with respect to information furnished in writing by Holder or
on Holder's behalf expressly for use in any registration statement or prospectus
relating to the Registrable Shares, or any amendment or supplement thereto, or
any preliminary prospectus.

     9.9 Indemnification Procedures. In case any proceeding (including any
governmental investigation) shall be instituted involving any person in respect
of which indemnity may be sought pursuant to this Section 9, such person (an
"INDEMNIFIED PARTY") shall promptly notify the person against whom such
indemnity may be sought (the "INDEMNIFYING PARTY") in writing and the
Indemnifying Party shall assume the defense thereof, including the employment of
counsel reasonably satisfactory to such Indemnified Party, and shall assume the
payment of all fees and expenses; provided that the failure of any Indemnified
Party so to notify the Indemnifying Party shall not relieve the Indemnifying
Party of its obligations hereunder except to the extent (and only to the extent
that) that the Indemnifying Party is materially prejudiced by such failure to
notify. In any such proceeding, any Indemnified Party shall have the right to
retain its own counsel, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party unless (a) the Indemnifying Party and the
Indemnified Party shall have mutually agreed to the retention of such counsel or
(b) in the reasonable judgment of such Indemnified Party representation of both
parties by the same counsel would be inappropriate due to actual or potential
differing interests between them. It is understood that the Indemnifying Party
shall not, in connection with any proceeding or related proceedings in the same
jurisdiction, be liable for the reasonable fees and expenses of more than one
separate firm of attorneys (in addition to any local counsel) at any time for
all such Indemnified Parties (including in the case of Holder, all of its
officers, directors and controlling persons) and that all such fees and expenses
shall be reimbursed as they are incurred. In the case of any such separate firm
for the Indemnified Parties, the Indemnified Parties shall designate such firm
in writing to the Indemnifying Party. The Indemnifying Party shall not be liable
for any settlement of any proceeding effected without its written consent (which
consent shall not be unreasonably withheld or delayed), but if settled with such
consent, or if there be a final judgment for the plaintiff, the Indemnifying
Party shall indemnify and hold harmless such Indemnified Parties from and
against any loss or liability (to the extent stated above) by reason of such
settlement or judgment. No Indemnifying Party shall, without the prior written
consent of the

                                     - 9 -
<PAGE>

Indemnified Party, effect any settlement of any pending or threatened proceeding
in respect of which any Indemnified Party is or could have been a party and
indemnity could have been sought hereunder by such Indemnified Party, unless
such settlement includes an unconditional release of such Indemnified Party from
all liability arising out of such proceeding.

     9.10 Contribution. To the extent any indemnification by an Indemnifying
Party is prohibited or limited by law, the Indemnifying Party agrees to make the
maximum contribution with respect to any amounts for which, he, she or it would
otherwise be liable under this Section 9 to the fullest extent permitted by law;
provided, however, that (a) no contribution shall be made under circumstances
where a party would not have been liable for indemnification under this Section
9 and (b) no seller of Registrable Securities guilty of fraudulent
misrepresentation (within the meaning used in the Securities Act) shall be
entitled to contribution from any party who was not guilty of such fraudulent
misrepresentation.

10. NONTRANSFERABILITY. Trilogy may not sell or transfer any Warrants to any
person other than a director, officer, employee, manager or affiliate of Trilogy
(or a person controlled by one or more directors, officers, employees, managers
or affiliates of Trilogy) or to a person or entity that assists Trilogy in
providing services to ABPH pursuant to the Letter of Engagement dated September
14, 2005 as the same may be amended from time to time, without the consent of
ABPH.

11. SEVERABILITY. If any term, provision, covenant or restriction of these
Warrants is held by a court of competent jurisdiction to be invalid, void or
unenforceable, the remainder of the terms, provisions, covenants and
restrictions of these Warrants shall remain in full force and effect and shall
in no way be affected, impaired or invalidated.

12. NOTICES. All notices, requests, consents and other communications required
hereunder shall be in writing and shall be effective when delivered or, if
delivered by registered or certified mail, postage prepaid, return receipt
requested, shall be effective on the third day following deposit in United
States mail: to the Holder, at Trilogy Capital Partners, Inc., 11726 San Vicente
Boulevard, Suite 235, Los Angeles, CA 90049; and if addressed to ABPH, at
Advanced BioPhotonics, Inc., 125 Wilbur Place, suite 120, Bohemia, NY 11716, or
such other address as Holder or ABPH may designate in writing.

13. NO RIGHTS AS SHAREHOLDER. The Holder shall have no rights as a shareholder
of ABPH with respect to the shares issuable upon exercise of the Warrants until
the receipt by ABPH of all of the Exercise Documents.

                                        Advanced BioPhotonics, Inc.

                                        By:
                                           -------------------------------------
                                           Denis A. O'Connor, President and CEO

                                     - 10 -
<PAGE>

                                   EXHIBIT "A"
                               NOTICE OF EXERCISE
                (To be signed only upon exercise of the Warrants)

To:      Advanced BioPhotonics, Inc.

         The undersigned hereby elects to purchase shares of Common Stock (the
"WARRANT SHARES") of Advanced BioPhotonics, Inc. ("ABPH"), pursuant to the terms
of the enclosed warrant certificate (the "CERTIFICATE"). The undersigned tenders
herewith payment of the exercise price pursuant to the terms of the Certificate.

         The undersigned hereby represents and warrants to, and agrees with,
ABPH as follows:

         1. Holder is acquiring the Warrant Shares for its own account, for
investment purposes only.

         2. Holder understands that an investment in the Warrant Shares involves
a high degree of risk, and Holder has the financial ability to bear the economic
risk of this investment in the Warrant Shares, including a complete loss of such
investment. Holder has adequate means for providing for its current financial
needs and has no need for liquidity with respect to this investment.

         3. Holder has such knowledge and experience in financial and business
matters that it is capable of evaluating the merits and risks of an investment
in the Warrant Shares and in protecting its own interest in connection with this
transaction.

         4. Holder understands that the Warrant Shares have not been registered
under the Securities Act or under any state securities laws. Holder is familiar
with the provisions of the Securities Act and Rule 144 thereunder and
understands that the restrictions on transfer on the Warrant Shares may result
in Holder being required to hold the Warrant Shares for an indefinite period of
time.

         5. Holder agrees not to sell, transfer, assign, gift, create a security
interest in, or otherwise dispose of, with or without consideration
(collectively, "TRANSFER") any of the Warrant Shares except pursuant to an
effective registration statement under the Securities Act or an exemption from
registration. As a further condition to any such Transfer, except in the event
that such Transfer is made pursuant to an effective registration statement under
the Securities Act, if in the reasonable opinion of counsel to ABPH any Transfer
of the Warrant Shares by the contemplated transferee thereof would not be exempt
from the registration and prospectus delivery requirements of the Securities
Act, ABPH may require the contemplated transferee to furnish ABPH with an
investment letter setting forth such information and agreements as may be
reasonably requested by ABPH to ensure compliance by such transferee with the
Securities Act.

<PAGE>

         Each certificate evidencing the Warrant Shares will bear the following
legend:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933 (THE "ACT") OR ANY APPLICABLE STATE SECURITIES LAWS
AND MAY NOT BE EXERCISED, SOLD, PLEDGED OR TRANSFERRED IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE ACT OR UNLESS AN
EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.

         6. Immediately following this exercise of Warrants, if as of the date
of exercise ABPH has a class of securities registered under Section 12 of the
Securities Exchange Act of 1934, as amended, the undersigned will not
beneficially own five percent (5%) or more of the then outstanding Common Stock
of ABPH (based on the number of shares outstanding set forth in the most recent
periodic report filed by ABPH with the Securities and Exchange Commission and
any additional shares which have been issued since that date of which Holder is
aware have been issued).

Number of Warrants Exercised:  ______________

Net Exercise  ____  Yes  ___ No

Dated:  ____________________

                                            ------------------------------------

                                      - 2 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]